[Osteoporosis in the elderly].
Osteoporosis is a frequent disease among the elderly and has major consequences in terms of mortality, morbidity and cost. Guidelines for diagnostic procedures are often difficult to apply in frail, elderly patients with multiple comorbidities. Bisphosphonates are the reference treatment for the elderly, combined with vitamin D and calcium supplementation. Vitamin D deficiency must also be treated to prevent falls and fractures. Strontium ranelate is a promising treatment in this population. Fall prevention is a major part of osteoporosis management. The potential benefit of hip protectors is questionable, even in institutionalized patients.
Retornaz
Frédérique
F
Division de gériatrie, Université McGill, Hôpital Général Juif, Montréal, Québec, Canada. frederique.retornaz@mail.mcgill.ca
Duque
Gustavo
G
D000058:Accidental Falls / Q000517:prevention & control; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000008:administration & dosage / Q000627:therapeutic use; D015444:Exercise; D005260:Female; D005264:Femoral Fractures / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D050723:Fractures, Bone / Q000453:epidemiology / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D016330:Frail Elderly; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000191:economics / Q000628:therapy; D011788:Quality of Life; D012307:Risk Factors; D012737:Sex Factors; D016103:Spinal Fractures / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D019379:Teriparatide / Q000008:administration & dosage / Q000627:therapeutic use; D013876:Thiophenes / Q000008:administration & dosage / Q000627:therapeutic use; D014807:Vitamin D / Q000008:administration & dosage / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000188:drug therapy
D050071:Bone Density Conservation Agents; D002136:Calcium, Dietary; D004164:Diphosphonates; D009942:Organometallic Compounds; D013876:Thiophenes; C081587:strontium ranelate; D019379:Teriparatide; D014807:Vitamin D